Peer Review History
| Original SubmissionAugust 20, 2019 |
|---|
|
PONE-D-19-23508 Is the number of previous hospitalizations associated with increased in-hospital mortality after hip fracture in a developing country? PLOS ONE Dear Mrs de Morais, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by Oct 20 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Felipe Hada Sanders, M.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. In ethics statement in the manuscript and in the online submission form, please provide additional information about the patient records used in your retrospective study. Specifically, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information. Additional Editor Comments (if provided): beautifully written. please attach the ethics comittee approval. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-19-23508R1 Is the number of previous hospitalizations associated with increased in-hospital mortality after hip fracture in a developing country? PLOS ONE Dear Mrs de Morais, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The authors are required to respond to the reviewers comments and make all necessary changes. We would appreciate receiving your revised manuscript by Mar 02 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Osama Farouk Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: (No Response) Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: (No Response) Reviewer #2: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: (No Response) Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: (No Response) Reviewer #2: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: General comments: It’s interesting to study the leading factors of mortality among hip fracture patients in addition to medical and public health importance, but this study idea titled “Is the number of previous hospitalizations associated with increased in-hospital mortality after hip fracture in a developing country?” raises some concerns. Unfortunately, the hypothesis and research question about the relation between one main diagnosis "what was found in records" and mortality in those patients is not based in scientific basis that we couldn't find in the introduction or discussion sections. Hip fracture is a condition mainly related to elderly, the mean age of patients in this study is 79.4 years (SD: 8.3) with expected complicated medical conditions in the past two years from the index hip fracture. With no doubt before conduction of this study, one reported diagnosis of previous hospitalizations is not the only related factor to the mortality among those patients with more than one morbidity condition in this study In addition, there are major defects in the manuscript and not well written especially in methods, data analysis and results sections. However, I have provided some remarks below. Abstract: In conclusion section: the word correlation is not correct to be written all over the manuscript, better to say associated factors or correlates. The sentences in lines 20 to 24 are not clear and not focused on the study aims, as “ evaluate , performance of hospitals, limited information system. “Correlates”: is mentioned in the title and didn’t mentioned after words anywhere all over the manuscript. In methods section: no data were mentioned about data collection The logistic regression analysis was not mentioned and its results “ which is not clear in analysis section after that” Introduction • Title and aim of the study are not matched with the introduction • First two paragraphs are not related to the title nor the aim of the study • Page 4, line 62: this study was not done to evaluate the quality of health care in hip fracture patients. • No need to write about evaluation of health care in hp fracture patients, this could be mentioned in one sentence. • Page 5, line 72 to 75: “Additionally, the national Hospital Admission Information System may serve as an instrument for the assessment of the quality of inpatient care. However, up to this moment the Brazilian Hospital Admission Information System still allows the recording of only one comorbidity and this information has been historically recorded poorly”….. this sentence about the poor data source is talking about a deficient tool to do this study, Methods: • Non concurrent: corrected to be retrospective cohort study • Between 2010 and 2011: could be corrected to be “ from the start of 2010 to the end of 2011” or whatever the included months. • Mention the level of significance of p value • Please mention the details of sensitivity analysis that was referred to in results section. Results: - Median of hospital stay duration: is this variable is non parametric?? Please clarify!! - Presentation of results is not well written regarding tables 2,3 and 4, the titles only were mentioned - Page 9, line 66 sensitivity analysis is firstly to be mentioned here. This analysis was not mentioned in methods section and no details here were presented. - N in tables: better to be corrected to “no.” - Table (1): • Total column could be moved after p value column for better understanding. • No. of previous hospitalization: is better to be grouped to 3 groups: “0, 1 and 2 and more”. Qui square test could be done correctly without “0” in any cell. • Write the test of significance as a footnote under the table. - Table (2): add number of mortalities in each diagnosis. - Table 3 and 4: - In general, the number of observations is lower than needed to carry logistic regression as in case of number of previous hospitalizations and ischemic heart disease. Number of mortalities in each diagnosis is not clear while number of cases was only mentioned. In general, regression analysis models were not done on statistical basis. • In the title “Multiple logistic regression models were adjusted for sex, age and type of fracture” please write this sentence as a footnote Discussion: • No discussion of the mortality incidence was found with other studies • Discussion should be rewritten after corrections in results section to reevaluate the significant relations Reviewer #2: Very interesting article. The major problem is the English language; abstract, introduction and methods are not clear. Seems like they have been written from a different person than the other parts. Abstract: I would change the phrase "That assessment.....systems" is too long, and in "restrospective...2011" there is no verb Introduction: You have analized too much what performance indicators are (I suggest to cancel 42-44 and 57-60 for example) Methods: ethical approval is repeated: 106-107, 132-134 ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Dalia G Mahran Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Is the number of previous hospitalizations associated with increased in-hospital mortality after hip fracture in a developing country? PONE-D-19-23508R2 Dear Dr. Pinheiro, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Osama Farouk Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: (No Response) Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: Dear Dr. Pinheiro, I am sorry about your loss. Your article is now sufficiently clear. I do appreciate your work. For the future, it would be interesting to analyze the association between comorbidity and fragility through mono- o multi-dimentional scales (like CIRS or MPI etc) and in-hospital mortality after a hip fracture, in this category of patients. Moreover, the adoption of the multidimensional scales of valuation during the hospitalization permit to get information even if the local hospital information systems have limited access to secondary diagnoses. It could be also important to evaluate if the patients undergo surgical treatment within 48 hours; this can be an important confounding factor. Best Regards ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No |
| Formally Accepted |
|
PONE-D-19-23508R2 Is the number of previous hospitalizations associated with increased in-hospital mortality after hip fracture in a developing country? Dear Dr. Pinheiro: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Osama Farouk Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .